25/09/2026 21:37
|
Manufacturing
Three-year initiative aims to address critical formulation and delivery challenges associated with high-dose dry powder biologic therapies
CRYSTAL LAKE, Ill.--BUSINESS WIRE--
Aptar Pharma, a...